申请人:Gillespy Timothy A.
公开号:US08658649B2
公开(公告)日:2014-02-25
The invention is directed to a compound of formula (I):
and the prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs. Such a compound has valuable pharmaceutical properties, in particular the ability to inhibit protein kinases.
该发明涉及公式(I)的化合物及其前药、药学上可接受的盐和溶剂化物以及这些化合物和其前药的药物学性质,其中这种化合物具有有价值的药理学特性,特别是抑制蛋白激酶的能力。